AMED:F:F-Amundi Index Solutions - Amundi ETF MSCI EMU ESG Leaders Select (EUR)

ETF | Others |

Last Closing

USD 313.5

Change

-5.60 (-1.75)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-13.90 (-2.46%)

USD 108.00B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-1.14 (-2.01%)

USD 105.77B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.84 (-1.64%)

USD 105.67B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.24 (-1.53%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

-2.80 (-2.78%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-4.05 (-1.74%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

-0.04 (-0.54%)

USD 41.48B
0ZC:F Zscaler Inc

-3.86 (-2.11%)

USD 37.92B
BSND:F Danone SA

+0.40 (+2.94%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-2.82 (-2.20%)

USD 24.77B

ETFs Containing AMED:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.81% 79% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.81% 79% B- 71% C-
Trailing 12 Months  
Capital Gain 9.18% 64% D 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.18% 62% D 53% F
Trailing 5 Years  
Capital Gain 77.16% 68% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.16% 68% D+ 50% F
Average Annual (5 Year Horizon)  
Capital Gain 11.73% 72% C 67% D+
Dividend Return 11.73% 70% C- 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.72% 45% F 81% B-
Risk Adjusted Return 79.70% 78% C+ 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.